Short Interest in Sernova Corp. (OTCMKTS:SEOVF) Drops By 35.1%

Sernova Corp. (OTCMKTS:SEOVF) was the target of a large drop in short interest in the month of June. As of June 15th, there was short interest totalling 7,400 shares, a drop of 35.1% from the May 31st total of 11,400 shares. Based on an average daily trading volume, of 55,300 shares, the days-to-cover ratio is presently 0.1 days.

Wall Street Analyst Weigh In

Separately, Raymond James assumed coverage on shares of Sernova in a report on Thursday, April 4th. They issued a “market perform” rating and a $1.50 target price on the stock.

Sernova Stock Up 0.5 %

Shares of Sernova stock traded up $0.00 during trading on Friday, hitting $0.25. 4,100 shares of the stock were exchanged, compared to its average volume of 19,386. The stock has a market cap of $75.90 million, a price-to-earnings ratio of -2.78 and a beta of 1.20. The firm’s 50-day moving average price is $0.26 and its 200 day moving average price is $0.38. The company has a debt-to-equity ratio of 0.14, a current ratio of 0.62 and a quick ratio of 1.20. Sernova has a 12-month low of $0.20 and a 12-month high of $0.81.

Sernova (OTCMKTS:SEOVF) last issued its quarterly earnings data on Friday, June 14th. The company reported ($0.02) earnings per share for the quarter.

Sernova Company Profile

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.